Platelets play an important role in atherothrombotic disease. The currently available antiplatelet drugs target key steps of platelet activation including thromboxane A 2 synthesis, ADP-mediated ...

Pharmacogenomics. 2014;15(4):509-528.

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Explore the latest advancements in heart disease medications, including statins, beta-blockers, ACE inhibitors, and more, for improved heart health.

Clinical practice guidelines on the use of antiplatelet therapy should aim to be more consistent in how they prioritize ischemic and bleeding risks across patient groups, argue the authors of a new ...

Fifth, some non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, may compete with aspirin for the cyclo-oxygenase 1 binding site and significantly interfere with the antiplatelet ...

The ARIES-HM3 substudy may help persuade implanters who are less well-versed in the circulatory changes an LVAD affords.

Background While dual antiplatelet therapy (dAPT) is standard of care following carotid artery stenting (CAS), the optimal dAPT regimen and duration has not been established. Methods We canvassed a ...

Turmeric tea is a great complementary treatment for inflammation to try alongside conventional recommendations. Learn how to ...

Sometimes you may receive a combination of therapies, or something else entirely. Oncology (cancer) drugs include a range of therapies and medications, such as chemotherapy drugs, targeted ...

INDICATION LEQEMBI® [ (lecanemab-irmb) 100 mg/mL injection for intravenous use] is indicated for the treatment of Alzheimer’s disease (AD). Treatment with LEQEMBI should be initiated in patients with ...